Pacific Vision Foundation
Usha Arunachalam is a seasoned professional with a strong background in business development and leadership within the biotechnology and pharmaceutical sectors. Currently serving as a Board Member at Pacific Vision Foundation since May 2016, Usha has held notable positions including Sr. Vice President of Business Development at Prolynx and Vice President of Business Development for various organizations such as The Leukemia & Lymphoma Society and Kosan Biosciences. Usha's experience also includes a tenure as CEO at Applied Protein Sciences, where Mucositis assets were sold to IndUS Pharmaceuticals, as well as consulting roles that highlight expertise in the industry. Usha holds an MBA from UCLA Anderson School of Management and a PhD in Biochemistry from the Indian Institute of Science.
This person is not in the org chart
This person is not in any teams
Pacific Vision Foundation
Pacific Vision Foundation (PVF) is dedicated to improving health equity in eye health and vision in collaboration with a community of physicians and other partners providing care and training. In 2020, PVF opened Pacific Vision Surgery Center, a brand-new 2 Operatory Room Ambulatory Surgery Center (ASC) in our Eye Institute building, to ensure more access to cataract, glaucoma and retina surgeries for patients from Federally Qualified Health Centers (FQHCs) referred to our partner Lions Eye Foundation (LEF)/CPMC/Sutter Clinic, which in turn refers patients to PVSC who need surgery, at no cost to them. For more than 40 years PVF has supported the physicians and researchers providing care to the under-served and has provided support services for the Department of Ophthalmology at California Pacific Medical Center (CPMC) Residency Program. Our work ensures the next generation of eye care specialists have the expertise they need to build thriving careers, while helping some of the most vulnerable members of our community gain access to sight-saving surgeries. PVF is proud to play a significant role in leading edge training and research, and direct line to access to care as we work towards equity in eye health.